ProHensor's Global Debut at Medica

 

 

We are absolutely thrilled to announce a landmark moment for Marins Med: our pioneering ProHensor upper-limb terminal device will be showcased at Medica, the world’s largest and most prestigious medical trade fair, this November in Düsseldorf, Germany.

Our product's journey to the global stage is spearheaded by Root 3 Labs, an exceptional engineering firm that has been instrumental in refining the ProHensor’s design for final manufacturing. Their expertise and dedication have not only enhanced the functionality of our device but have also brought us to the cusp of a new horizon in prosthetic technology.

 

 

At Marins Med, our mission is to empower active upper-limb amputees to reclaim their desired activities with the introduction of an innovative terminal device that aligns with durability and functionality. The ProHensor is the embodiment of this mission. Special for the convention, the ProHensor will be fitted with an innovative clear cap exoskeleton. This feature is more than aesthetic; it's a window into the intricate workings of our technical locking mechanism, revealing the precision and care embedded in every aspect of our design.

Delegates at Medica will be among the first to witness the unveiling of the ProHensor prototype, presented by the very engineers who know it best. This is more than an exhibition; it's an educational experience, a conversation starter, and most importantly, a testament to human-centric engineering.

 

 

As the second week of November approaches, we eagerly anticipate the impact that ProHensor will have on the international community. We believe that our presence at Medica, a gathering of the world's most innovative minds in medicine, will not only introduce our product but will also forge new pathways for collaboration and advancement.

Stay tuned for updates on our journey at Medica and witness the strides we're making in the field of prosthetic technology. The future is within our grasp, and it looks promising with the ProHensor.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.